Abstract
New antidibatic drugs: inhibitors of DPP-4 and GLP-1 agonists are very effective, good tolerated and safe drugs for type 2 diabetes treatment. Subcutaneously aplicated GLP-1 agonists reduce blood pressure more than inhibitors of DPP-4.
Inhibitors of DPP-4 reduce blood pressure a little more than placebo and have neutral cardiovascular effect.